These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 1632287)

  • 61. Thromboxane A2-mimetics are potent microvascular permeability factors in the conjunctiva.
    Woodward DF; Nieves AL; Williams LS
    J Pharmacol Exp Ther; 1990 Oct; 255(1):23-7. PubMed ID: 2213558
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Agents combining thromboxane receptor antagonism with thromboxane synthase inhibition: [[[2-(1H-imidazol-1-yl)ethylidene]amino]oxy]alkanoic acids.
    Cozzi P; Giordani A; Menichincheri M; Pillan A; Pinciroli V; Rossi A; Tonani R; Volpi D; Tamburin M; Ferrario R
    J Med Chem; 1994 Oct; 37(21):3588-604. PubMed ID: 7932586
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effects of endogenous and synthetic prostanoids, the thromboxane A2 receptor agonist U-46619 and arachidonic acid on [3H]-noradrenaline release and vascular tone in rat isolated kidney.
    Rump LC; Schollmeyer P
    Br J Pharmacol; 1989 Jul; 97(3):819-28. PubMed ID: 2503228
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505.
    Sjöberg T; Steen S
    Acta Physiol Scand; 1989 Jun; 136(2):161-5. PubMed ID: 2528885
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Differences in activities of thromboxane A2 receptor antagonists in smooth muscle cells.
    Miki I; Kase H; Ishii A
    Eur J Pharmacol; 1992 Oct; 227(2):199-204. PubMed ID: 1426029
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane.
    Maassen VanDenBrink A; Bax WA; Ferrari MD; Zijlstra FJ; Bos E; Saxena PR
    Br J Pharmacol; 1996 Nov; 119(5):855-62. PubMed ID: 8922732
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thromboxane A2 and vascular smooth muscle cell proliferation.
    Sachinidis A; Flesch M; Ko Y; Schrör K; Böhm M; Düsing R; Vetter H
    Hypertension; 1995 Nov; 26(5):771-80. PubMed ID: 7591017
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Androgen regulation of thromboxane A2/prostaglandin H2 receptor expression in human erythroleukemia cells.
    Matsuda K; Mathur RS; Duzic E; Halushka PV
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E928-34. PubMed ID: 8279549
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Effects of free and macromolecular-bound TXA2 receptor antagonist BM 13.505 on U46619-induced platelet aggregation.
    Klimm JL; Kloczewiak MA; Lindon J
    Prostaglandins; 1993 Jul; 46(1):27-36. PubMed ID: 8378540
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease.
    Fiedler VB; Seuter F; Perzborn E
    Stroke; 1990 Dec; 21(12 Suppl):IV149-51. PubMed ID: 2260140
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Glibenclamide inhibits thromboxane-mediated vasoconstriction by thromboxane receptor blockade.
    Pfister SL; Pratt PE; Kurian J; Campbell WB
    Vascul Pharmacol; 2004 Jan; 40(6):285-92. PubMed ID: 15063832
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
    Spurney RF; Middleton JP; Raymond JR; Coffman TM
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Synthesis and dual antagonistic activity against thromboxane A2 and leukotriene D4 of benzenesulfonamide derivatives].
    Sakurai S; Ogawa N; Onogi Y; Ohashi T; Kado N; Yasuda S; Kato H
    Yakugaku Zasshi; 1997 May; 117(5):298-318. PubMed ID: 9194397
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Labeling of human platelet plasma membrane thromboxane A2/prostaglandin H2 receptors using SQB, a novel biotinylated receptor probe.
    Komiotis D; Wencel-Drake JD; Dieter JP; Lim CT; Le Breton GC
    Biochem Pharmacol; 1996 Sep; 52(5):763-70. PubMed ID: 8765474
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Receptor-mediated effect of a synthetic thromboxane-analogue on cytosolic calcium in isolated proximal tubules.
    Reyes JL; Nava E; Namorado MC
    Prostaglandins; 1992 Aug; 44(2):145-54. PubMed ID: 1438878
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The tripeptide ZAMI-420 inhibits thromboxane-induced gastric vasoconstriction and ischaemia.
    Moroni D; Gervasi GB; Patella P; Visentin L; Maselli MA; Bergamaschi M
    Int J Tissue React; 1983; 5(3):249-52. PubMed ID: 6654624
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Computer-aided molecular modeling of a thromboxane receptor antagonist S-145 and its related compounds.
    Ezumi K; Yamakawa M; Narisada M
    J Med Chem; 1990 Apr; 33(4):1117-22. PubMed ID: 2138675
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The effects of eicozanoids and lipoxygenase inhibitors on the lipid metabolism of aortic cells.
    Tertov VV; Panosyan AG; Akopov SE; Orekhov AN
    Biomed Biochim Acta; 1988; 47(10-11):S286-8. PubMed ID: 3150271
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptors.
    Okwu AK; Mais DE; Halushka PV
    Biochim Biophys Acta; 1994 Mar; 1221(1):83-8. PubMed ID: 8130280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.